Tonix Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.About TNXP
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800.
TNXP Key Statistics
Stock Snapshot
With a market cap of 199.49M, Tonix Pharmaceuticals(TNXP) trades at $15.90. The stock has a price-to-earnings ratio of -0.02.
As of 2026-01-01, Tonix Pharmaceuticals(TNXP) stock has fluctuated between $15.47 and $16.11. The current price stands at $15.90, placing the stock +2.8% above today's low and -1.3% off the high.
The Tonix Pharmaceuticals(TNXP)'s current trading volume is 606.55K, compared to an average daily volume of 523.34K.
During the past year, Tonix Pharmaceuticals(TNXP) stock moved between $6.76 at its lowest and $69.97 at its peak.
During the past year, Tonix Pharmaceuticals(TNXP) stock moved between $6.76 at its lowest and $69.97 at its peak.
TNXP News
Claim 70% Off TipRanks This Holiday Season Tonix Pharma ( (TNXP) ) just unveiled an announcement. On December 29, 2025, Tonix Pharmaceuticals entered into a s...
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) on Monday announced program updates on TNX-4800 (formerly known as mAb 2217LS), a long-acting human monoclonal...
Tonix Pharmaceuticals (TNXP) entered into a securities purchase agreement with Point72 for the purchase and sale of 615,025 shares of its common stock at an off...
More TNXP News
Tonix Pharmaceuticals (TNXP) announced program updates on TNX-4800, which is a long-acting human monoclonal antibody that targets the outer surface protein A of...